Proteomic analysis of differential protein expression by brain metastases of gynecological malignancies

Human Cell

Volumn 26, Issue 2, 2013, Pages 56-66

  Yoshida, Ayako ^a   Okamoto, Naoki ^a   Tozawa Ono, Akiko ^a   Koizumi, Hirotaka ^a   Kiguchi, Kazushige ^a   Ishizuka, Bunpei ^a   Kumai, Toshio ^b   Suzuki, Nao ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alpha enolase; Brain metastasis; Gynecological malignancies; Transgelin 2; Triosephosphate isomerase

Indexed keywords

ALPHA ENOLASE; TRANSGELIN; TRANSGELIN 2; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG;

ARTICLE; BRAIN METASTASIS; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; GYNECOLOGIC CANCER; GYNECOLOGIC SURGERY; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; OVARY CANCER; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TANDEM MASS SPECTROMETRY; UTERINE CERVIX CANCER; WESTERN BLOTTING;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CHROMATOGRAPHY, LIQUID; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84878863276     PISSN: 09147470     EISSN: 17490774     Source Type: Journal    
DOI: 10.1007/s13577-012-0053-4     Document Type: Article

References (38)

1. Matsuda T, Marugame T, Kamo K, et al. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2011;41: 139-47.
2. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes memorial award lecture. Cancer Res. 1990;50: 6130-8.
3. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol. 1998;153: 333-9.
4. Nathoo N, Chahlavi A, Barnett GH, Toms SA. Pathobiology of brain metastases. J Clin Pathol. 2005;58: 237-42.
5. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8: 98-101.
6. Fagundes H, Perez CA, Grigsby PW, Lockett MA. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1992;24: 197-204.
7. Mariani A, Webb MJ, Keeney GL, et al. Hematogenous dissemination in corpus cancer. Gynecol Oncol. 2001;80: 233-8.
8. Anupol N, Ghamande S, Odunsi K, et al. Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases. Gynecol Oncol. 2002;85: 487-92.
9. Committee of Brain Tumor Registry of Japan. Report of Brain Tumor Registry of Japan (1969-1996). Neurol Med Chir (Tokyo) 2003;43 Suppl: i, vii, 1-111.
10. Kolomainen DF, Larkin JM, Badran M, et al. Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol. 2002;20: 982-6.
11. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406: 747-52.
12. Cravatt BF, Sorensen EJ. Chemical strategies for the global analysis of protein function. Curr Opin Chem Biol. 2000;4: 663-8.
13. Roesli C, Borgia B, Schliemann C, et al. Comparative analysis of the membrane proteome of closely related metastatic and nonmetastatic tumor cells. Cancer Res. 2009;69: 5406-14.
14. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100: 57-70.
15. Yu Y, Shen H, Yu H, et al. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis. Mol BioSyst. 2011;7: 1908-16.
16. Thongwatchara P, Promwikorn W, Srisomsap C, et al. Differential protein expression in primary breast cancer and matched axillary node metastasis. Oncol Rep. 2011;26: 185-91.
17. Yao H, Zhang Z, Xiao Z, et al. Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer. 2009;65: 41-8.
18. Shi SR, Liu C, Balgley BM, et al. Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem. 2006;54: 739-43.
19. Gregory JD, Sajdera SW. Interference in the Lowry method for protein determination. Science. 1970;169: 97-8.
20. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002;74: 5383-92.
21. Chen EI, Hewel J, Krueger JS, et al. Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res. 2007;67: 1472-86.
22. Wu W, Tang X, Hu W, et al. Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis. 2002;19: 319-26.
23. Duran MC, Vega F, Moreno-Bueno G, et al. Characterisation of tumoral markers correlated with ErbB2 (HER2/Neu) overexpression and metastasis in breast cancer. Proteomics Clin Appl. 2008;2: 1313-26.
24. Rait VK, Xu L, O'Leary TJ, Mason JT. Modeling formalin fixation and antigen retrieval with bovine pancreatic RNase A II. Interrelationship of cross-linking, immunoreactivity, and heat treatment. Lab Invest. 2004;84: 300-6.
25. Prieto DA, Hood BL, Darfler MM, et al. Liquid Tissue: proteomic profiling of formalin-fixed tissues. BioTechniques 2005;Suppl: 32-5.
26. Ono A, Kumai T, Koizumi H, et al. Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues. Hum Pathol. 2009;40: 41-9.
27. Shapland C, Hsuan JJ, Totty NF, Lawson D. Purification and properties of transgelin: a transformation and shape change sensitive actin-gelling protein. J Cell Biol. 1993;121: 1065-73.
28. Shields JM, Rogers-Graham K, Der CJ. Loss of transgelin in breast and colon tumors and in RIE-1 cells by Ras deregulation of gene expression through Raf-independent pathways. J Biol Chem. 2002;277: 9790-9.
29. Robert J, van Rymenant M, Lagae F. Enzymes in cancer. III. Triosephosphate isomerase activity of human blood serum in normal individuals and in individuals with various pathological conditions. Cancer. 1961;14: 1166-74.
30. Zhang D, Tai LK, Wong LL, et al. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer. Mol Cell Proteomics. 2005;4: 1686-96.
31. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci. 2001;58: 902-20.
32. Hamaguchi T, Iizuka N, Tsunedomi R, et al. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Int J Oncol. 2008;33: 725-31.
33. Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature. 1999;401: 173-7.
34. Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res. 2008;18: 452-7.
35. Chang HJ, Lee MR, Hong SH, et al. Identification of mitochondrial FoF1-ATP synthase involved in liver metastasis of colorectal cancer. Cancer Sci. 2007;98: 1184-91.
36. Christiano AP, Yoshida BA, Dubauskas Z, et al. Development of markers of prostate cancer metastasis. Review and perspective. Urol Oncol. 2000;5: 217-23.
37. MacDonald NJ, Steeg PS. Molecular basis of tumour metastasis. Cancer Surv. 1993;16: 175-99.
38. Navin N, Kendall J, Troge J, et al. Tumour evolution inferred by single-cell sequencing. Nature. 2011;472: 90-4.